Yukiharu Nakabo, Tatsuya Katsurada, Yataro Yoshida (The Center for Hematological Diseases , Takeda General Hospital, Kyoto, Japan)

Hideyoshi Noji^1,11,12, Yasutaka Ueda^2,12, Naoshi Obara^3,12, Yoshinobu Kanda^4,12, Shinichiro Okamoto^5,12, Kensuke Usuki^6,12, Takahisa Matsuda⁷, Hirozumi Akiyama⁷, Masanori Takahashi⁷, Yuji Yonemura^8,12, Tatsuya Kawaguchi^9,12, Jun-Ichi Nishimura^2,12, Takayuki Ikezoe^1,12, Shigeru Chiba^3,12, Yuzuru Kanakura^2,12, Haruhiko Ninomiya^10,12 (1.Department of Hematology, Fukushima Medical University, Fukushima, Japan., 2.Department of Hematology and Oncology, Osaka University, Suita, Japan., 3.Department of Hematology, Faculty_of_Medicine, University of Tsukuba, Tsukuba, Japan., 4.Division of Hematology, Jichi Medical University, Shimotsuke, Japan., 5.Division of Hematology, Department of Internal_Medicine, Keio University, Tokyo, Japan., 6.Department of Hematology, NTT Medical Center Tokyo, Tokyo Japan., 7.Alexion Pharma G.K., Tokyo, Japan, 8.Department of Transfusion_Medicine and Cell_Therapy, Blood_Transfusion_Service, Kumamoto University, Kumamoto, Japan., 9.Kumamoto Health Science University, Kumamoto, Japan., 10.Department of Medical_Sciences, Faculty_of_Medicine, University of Tsukuba, Tsukuba, Japan., 11.Department of Medical_Oncology, Fukushima Medical University, Fukushima, Japan., 12.Japan PNH Study Group, Tokyo, Japan)

Yoshio Iwata¹, Yasuyoshi Morita¹, Kiyoshi Tsuji², Shinya Rai¹, Takayuki Tasaki², Hiroaki Inoue¹, Yasuhiro Taniguchi¹, Ko Fujimoto¹, Hirokazu Tanaka¹, Takashi Ashida¹, Amami Kato², Itaru Matsumura¹ (1.Dept. of Hematol. and Rheumatol., Kindai Univ., Osaka, Japan, 2.Dept. of Neurosurgery, Kindai Univ., Osaka, Japan)

Seara Ikeno^1,2, Motohito Okabe¹, Yuka Kawaguchi¹, Marie Ohbiki¹, Yoonha Lee¹, Masahide Osaki¹, Miyo Goto¹, Hiroaki Araie¹, Takahiko Sato¹, Takanobu Morishita¹, Yukiyasu Ozawa¹, Akira Katsumi², Koichi Miyamura¹ (1.Department of Hematology, Japanese Red Cross Nagoya First Hospital, Japan, 2.Department of Hematology, National Center for Geriatrics and Gerontology, Japan)

Hiroaki Asai¹, Kazuto Takeuchi¹, Yuichi Ikeda², Toshiki Ochi², Kazushi Tanimoto², Jun Yamanouchi², Taichi Azuma², Hiroshi Fujiwara², Takaaki Hato², Masaki Yasukawa², Yoshihiro Yakushijin³ (1.Oncology Center, Ehime Univ. Hospital, Ehime, Japan, 2.Hematology, Clinical Immunology and Infectious Diseases, Ehime Univ., Ehime, Japan, 3.Clinical Oncology, Ehime Univ., Ehime, Japan)

Shota Nono, Yasuko Kajimura, Shunsuke Hiroshige, Takuro Matsumura, Takanori Tominaga, Toru Takahashi (Hematol., Yamagchi prefectural grand medical center. Yamaguchi, Japan)

Ken Ishiyama¹, Jong Wook Lee², Scott T. Rottinghaus³, Lily Wong Lee Lee⁴, Viviani Pessoa⁵, Sandra Gualandro⁶, Wolfgang Fureder⁷, Vadim Ptushkin⁸, Flore Sicre De Fontbrune⁹, Lori Volles³, Andrew I Damokosh³, Rasha Aguzzi¹⁰, Rajendra Pradhan³, Stephan Ortiz³, Hubert Schrezenmeier¹¹, Anita Hill¹² (1.Hematology, Kanazawa University Hospital, Ishikawa, Japan, 2.Seoul St. Mary's Hospital, Seoul, South Korea, 3.Alexion Pharmaceuticals, Inc., New Haven, CT, USA, 4.Hematology Unit, Queen Elizabeth Hospital, Kota Kinabalu, Sabah, Malaysia, 5.Hematology, Hemorio, Rio de Janeiro, Brazil, 6.University of Sao Paulo Medical School, Sao Paulo, Brazil, 7.Division of Hematology & Hemostaseology, Medical University of Vienna, Austria, 8.S.P. Botkin Hospital, Moscow, Russia, 9.Hospital Saint-Louis, Paris, France, 10.Alexion Pharmaceuticals, Inc., Lexington, MA, USA, 11.Institute of Transfusion Medicine, University of Ulm, German, 12.Department of Haematology, Leeds Teaching Hospitals, Leeds, UK)

Yuma Noguchi^1,2, Akihiko Nishijima², Yuki Osada², Kensuke Narukawa², Hina Takano³, Gaku Oshikawa² (1.Hematol., Tokyo Medical and Dental Univ., Tokyo, Japan, 2.Department of Hematology, Japanese Red Cross Musashino Hospital, Tokyo, Japan, 3.Department of Transfusion, Japanese Red Cross Musashino Hospital, Tokyo, Japan)